spacer
home > pmps > summer 2007 > drug packaging – the prescription for success
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Drug Packaging – The Prescription for Success

Tassilo Korab at the Healthcare Compliance Packaging Council of Europe (HCPC Europe)

Do you know this feeling? You are about to leave your home, you are in a hurry and all of a sudden there are those nagging doubts about whether or not you have taken your medication this morning. You go back to the bathroom, but checking the pack with the medication doesn’t help. There is nothing that indicates whether you have taken your daily dose, and since you don’t want to risk an overdose, you shut the medicine cupboard and leave home, taking your doubts and concerns with you.

People who have to follow a medicinal regimen often have this experience. In addition, the number of medications people have to take often increases with age, as does the risk of non-adherence to the regimen. Many of these people are not really ‘patients’ at all. They don’t suffer in any way, but they most likely will at a later date if their condition remains untreated. They may, for example, have been diagnosed with high blood pressure or an increased level of cholesterol.

In some cases, medicinal treatment will not be able to remove the cause of the condition but will control it to such a level that a good quality of life with little or no restraints can be enjoyed. Such treatment, called secondary prevention, is an essential part of healthcare and is a key element in the cost effectiveness of healthcare expenditure. Pennies not spent on prudent secondary prevention may cost many pounds at a later date.

Clinical trials and data ascertained about the human body’s reaction to modern medicines provide proof of the importance of patient compliance. The introduction of antibiotics highlighted the dangers of non-compliance more than any drug in the past. The consequences were looked at, widening the scope of the investigations from just the failure of the treatment to the causes, the forms and the cost of non-compliance, as well as its impact on public health.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
spacer
Tassilo Korab
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Phillips-Medisize Enters Agreement with Global Pharmaceutical Company to Acquire Exclusive Ownership of Patents for an Innovative Mini-tablet Dispenser

HUDSON, WI – September 10, 2019 – Phillips-Medisize, a Molex company, announced today an agreement with a Global Pharmaceutical Company, where Phillips-Medisize acquired exclusive ownership of patents supporting an innovative mini-tablet dispenser to accommodate the varied and customized oral dispensing needs of patients.
More info >>

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement